Medicare drug price negotiations to target Ozempic, Wegovy and other drugs

Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, as well as some blockbuster cancer medications and other drugs, for its second round of price talks. 

Together with the first 10 drugs that the Biden administration targeted for its Medicare Drug Price Negotiation Program last year, the medications make up a third of prescription drug spending in the government insurance program for seniors.

Prices negotiated in this second round of talks are slated to take effect in 2027. The drugs announced Friday by the Biden administration are: